Sort   by:  
 Page size 
UnknownClinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib.
Not available
S-EPMC3956829 | biostudies-literature
UnknownLBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study
Not available
S-EPMC7506488 | biostudies-literature
UnknownReal-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program.
Not available
S-EPMC6448290 | biostudies-literature
UnknownThe changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?
Not available
S-EPMC4401714 | biostudies-literature
UnknownSymptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Not available
S-EPMC7649863 | biostudies-literature
Sort   by:  
 Page size